Quarterly Updates25 May 2026, 08:01 pm
Orchid Pharma FY26: Revenue ₹811.33 Mn, Net Profit ₹45.21 Mn
AI Summary
Orchid Pharma Ltd announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The company reported total income of ₹866.57 Mn and net profit of ₹45.21 Mn for the year. The board also approved the appointment of an internal auditor for the financial year 2026-27.
Key Highlights
- Orchid Pharma's FY26 revenue from operations stood at ₹811.33 Mn.
- The company's net profit for FY26 was reported as ₹45.21 Mn.
- Board approved the appointment of Internal Auditor for FY 2026-27.
- Auditors report with modified opinion for consolidated financial results.
- Auditors report with unmodified opinion for standalone financial results.
Price Impact
More from ORCHIDPHAR